Dr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical Study
Stock Information for Theralase Technologies Inc.
Loading
Please wait while we load your information from QuoteMedia.